Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.41 |
| ▸ | FABP7 | O15540 | 2/20 | 0.41 |
| ▸ | HTRA1 | Q92743 | 1/20 | 0.38 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.36 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6376524 | 0.93 | CASP1 (0.43) | POLBCYP1A2CYP2C19CYP3A4CASP1 | |
| SCHEMBL31000711 | 0.93 | CASP1 (0.43) | POLBCYP1A2CYP2C19CYP3A4CASP1 | |
| SCHEMBL12863461 | 0.85 | BACE1 (0.42) | POLBCYP1A2CYP2C19CYP3A4CASP1 | |
| SCHEMBL3789335 | 0.84 | KMT2A (0.43) | POLBCYP1A2CYP2C19FABP5FABP7 | |
| SCHEMBL3793423 | 0.84 | KMT2A (0.43) | POLBCYP1A2CYP2C19FABP5FABP7 | |
| SCHEMBL3788777 | 0.84 | KMT2A (0.43) | POLBCYP1A2CYP2C19FABP5FABP7 | |
| SCHEMBL3783542 | 0.84 | KMT2A (0.43) | POLBCYP1A2CYP2C19FABP5FABP7 | |
| SCHEMBL4249277 | 0.84 | KMT2A (0.43) | POLBCYP1A2CYP2C19FABP5FABP7 | |
| SCHEMBL2899441 | 0.82 | POLB (0.50) | POLBFABP5FABP7KMT2AEPHX2 | |
| SCHEMBL30089351 | 0.82 | POLB (0.50) | POLBFABP5FABP7KMT2AEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3792250-A1 | SYNTHESIS OF ALPHA-AMANITIN AND ITS DERIVATIVES | Pure Bioorganics SIA (LV) | 2021-03-17 | — | — | EP | disclosed |
| WO-2021004973-A1 | SYNTHESIS OF A-AMANITIN AND ITS DERIVATIVES | PURE BIOORGANICS SIA (LV) | 2021-01-14 | — | — | WO | disclosed |